Site icon pharmaceutical daily

Sanofi appoints new EVP Diabetes & Cardiovascular

A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo

A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo

Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.

Sanofi said that in this role, Oelrich will be a member of the Executive Committee. He has served as Acting Head of DCV North America business since July.

Oelrich previously served as head of Sanofi’s global diabetes franchise since June 2016. Prior to that, Oelrich held the role of DCV Europe Region Head & Sanofi Europe Coordinator, and he was heavily involved in establishing the DCV global business unit since mid-2015. Between 2011 and 2015 he served as General Manager in Germany, Switzerland and Austria.

 

Exit mobile version